Recent Advances to Augment NK Cell Cancer Immunotherapy Using Nanoparticles

Among various immunotherapies, natural killer (NK) cell cancer immunotherapy using adoptive transfer of NK cells takes a unique position by targeting tumor cells that evade the host immune surveillance. As the first-line innate effector cell, it has been revealed that NK cells have distinct mechanis...

Full description

Bibliographic Details

Published in:	Pharmaceutics
Main Authors:	Kwang-Soo Kim, Dong-Hwan Kim, Dong-Hyun Kim
Format:	Article
Language:	English
Published:	MDPI AG 2021-04-01
Subjects:	nanoparticles NK cell therapy cancer immunotherapy tumor microenvironment NK cell activation
Online Access:	https://www.mdpi.com/1999-4923/13/4/525